Deployment evaluation · 14

Comparative benefit and harm

Compare the robotic pathway with relevant standard care using patient-important outcomes and complete resource use.

Evidence statusClinical evidence framework · intended use, jurisdiction and care-pathway validation requiredLast reviewed: 15 August 2026
14

FUURAA thesis

Technical improvement is clinically valuable only when net benefit survives a fair comparison.

Engineering map

Turn the title into engineering objects that can be observed, measured and reviewed.

Each layer states the boundary to establish and the evidence needed for the next decision.

01

Comparator

Use the care pathway patients would otherwise receive at comparable expertise.

02

Outcomes

Include harm, recovery, function, reintervention and quality of life where relevant.

03

Resources

Count setup, staff, consumables, conversion, maintenance and length of stay.

Verification questions

Write the questions first, then decide whether a demo, test, pilot or operating record can answer them.

Each question needs an object, conditions, denominator, threshold and accountable decision owner.

  1. 01

    Is the comparator contemporary and relevant?

  2. 02

    Are patient-important harms captured?

  3. 03

    How does experience affect results?

  4. 04

    Are missing outcomes explained?

Evidence to preserve

Enable the next reader to reconstruct conditions, results, failures and the decision.

A conclusion alone loses reviewability; raw records, configuration and exclusions matter too.

  1. 01

    Evidence package 1

    Prespecified comparative protocol

  2. 02

    Evidence package 2

    Complete benefit-harm outcome table

  3. 03

    Evidence package 3

    Sensitivity and subgroup analysis

Scope boundary

State what this evidence still cannot be generalised to.

Sources and evidence status

Read standards scope, measurement evidence and application conclusions separately.

Source dates and review status remain visible; external sources open in a new tab.